We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
-11.33%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$15.1B
AUM Growth
-$1.81B
(-11%)
Cap. Flow
+$464M
Cap. Flow
% of AUM
3.07%
Top 10 Holdings %
Top 10 Hldgs %
22.68%
Holding
1,302
New
77
Increased
452
Reduced
571
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$835M |
| 2 |
Procter & Gamble
PG
|
+$87.9M |
| 3 |
Alibaba
BABA
|
+$50.4M |
| 4 |
Merck
MRK
|
+$47.1M |
| 5 |
Target
TGT
|
+$42.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$105M |
| 2 |
Texas Instruments
TXN
|
+$79.4M |
| 3 |
TSMC
TSM
|
+$77.5M |
| 4 |
Cisco
CSCO
|
+$55.8M |
| 5 |
NextEra Energy
NEE
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.2% |
| 2 | Healthcare | 16.02% |
| 3 | Financials | 13.93% |
| 4 | Communication Services | 9.97% |
| 5 | Consumer Discretionary | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Xencor
XNCR
$1.59B
| $514K | ﹤0.01% |
14,900
-3,300
| -18% | -$121K |
|
827
W.P. Carey
WPC
$16.1B
| $513K | ﹤0.01% |
+7,425
| New | +$483K |
|
828
Euronet Worldwide
EEFT
$2.65B
| $507K | ﹤0.01% |
+5,000
| New | +$554K |
|
829
Designer Brands
DBI
$333M
| $505K | ﹤0.01% |
20,382
+2,925
| +17% | +$78.5K |
|
830
Voya Financial
VOYA
$9.21B
| $501K | ﹤0.01% |
12,055
-25,345
| -68% | -$1.13M |
|
|
VER
831
DELISTED
VEREIT, Inc.
VER
| $499K | ﹤0.01% |
13,157
+310
| +2% | +$11.5K |
|
832
Opko Health
OPK
$1.03B
| $497K | ﹤0.01% |
196,274
-43,500
| -18% | -$147K |
|
833
Energy Transfer Partners
ET
$70.7B
| $493K | ﹤0.01% |
+38,400
| New | +$583K |
|
834
Match Group
MTCH
$8.43B
| $490K | ﹤0.01% |
+11,500
| New | +$529K |
|
835
National Health Investors
NHI
$3.61B
| $490K | ﹤0.01% |
6,412
| – | – |
|
|
SGMO
836
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $489K | ﹤0.01% |
46,200
-10,500
| -19% | -$130K |
|
837
Franco-Nevada
FNV
$46.1B
| $483K | ﹤0.01% |
6,936
+988
| +17% | +$66K |
|
838
Evercore
EVR
$11.4B
| $480K | ﹤0.01% |
6,900
+2,400
| +53% | +$197K |
|
839
Flowserve
FLS
$10.1B
| $472K | ﹤0.01% |
12,008
-2,631
| -18% | -$123K |
|
|
VISN
840
Vistance Networks Inc
VISN
$2.62B
| $471K | ﹤0.01% |
28,132
+2,627
| +10% | +$55.7K |
|
|
ZAYO
841
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $468K | ﹤0.01% |
20,214
+1,461
| +8% | +$40K |
|
842
Insmed
INSM
$29B
| $467K | ﹤0.01% |
35,900
+2,400
| +7% | +$38.3K |
|
843
Albemarle
ALB
$15.4B
| $463K | ﹤0.01% |
5,620
-178
| -3% | -$16.8K |
|
|
RUBY
844
DELISTED
Rubius Therapeutics, Inc
RUBY
| $457K | ﹤0.01% |
+29,000
| New | +$529K |
|
845
East-West Bancorp
EWBC
$18B
| $456K | ﹤0.01% |
10,081
-946
| -9% | -$49K |
|
|
EV
846
DELISTED
Eaton Vance Corp.
EV
| $456K | ﹤0.01% |
12,244
-6,234
| -34% | -$263K |
|
|
CYBR
847
DELISTED
CyberArk
CYBR
| $454K | ﹤0.01% |
6,263
+4,418
| +239% | +$316K |
|
|
AERI
848
DELISTED
Aerie Pharmaceuticals
AERI
| $443K | ﹤0.01% |
12,400
-2,800
| -18% | -$131K |
|
849
Travel + Leisure Co
TNL
$4.49B
| $438K | ﹤0.01% |
12,100
-11,200
| -48% | -$436K |
|
850
Energizer
ENR
$1.5B
| $429K | ﹤0.01% |
9,500
-71,340
| -88% | -$3.79M |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q4 2018 Portfolio in Review
As of Q4 2018, DekaBank Deutsche Girozentrale held 1,302 positions worth $15.1B, down 11% from $16.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
DekaBank Deutsche Girozentrale deployed $464M of net new capital in Q4 2018, opening 77 new positions and adding to 452 existing holdings. Its largest new stake was Linde: 5,283,074 shares worth $840M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $105M trimmed.
- DekaBank Deutsche Girozentrale's largest Q4 2018 buy was Linde: 5,283,074 shares worth $840M.
- DekaBank Deutsche Girozentrale added most to Procter & Gamble in Q4 2018, an estimated $87.9M increase.
- DekaBank Deutsche Girozentrale's biggest Q4 2018 reduction was Johnson & Johnson, cutting an estimated $105M.
- DekaBank Deutsche Girozentrale fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $46.5M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $15.1B portfolio in Q4 2018.
- DekaBank Deutsche Girozentrale opened 77 new positions and closed 126 in Q4 2018.
- DekaBank Deutsche Girozentrale's portfolio value fell 11% quarter-over-quarter to $15.1B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2018, filed 12 Feb 2019.